EdgarLookup

Phio Pharmaceuticals Corp. — All Filings

863 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 25-NSE 3 3/A 4 4/A 424B2 424B3 424B4 424B5 8-A12B 8-A12G 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A DEFA14A EFFECT FWP POS AM POS EX PRE 14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-8 SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SP 15D2 UPLOAD
Form Description Accession Number Filed Period
S-3 REGISTRATION STATEMENT 0001683168-25-006179 Aug 15, 2025
8-K CURRENT REPORT 0001683168-25-006171 Aug 14, 2025
10-Q FORM 10-Q FOR JUN 2025 0001683168-25-006174 Aug 14, 2025 Jun 30, 2025
SCHEDULE 13G/A 0001641172-25-022581 Aug 7, 2025
D 0001123292-25-000336 Aug 4, 2025
8-K FORM 8-K 0001683168-25-005523 Jul 30, 2025 Jul 25, 2025
DEFA14A ADDITIONAL DEFINITIVE PROXY MATERIALS 0001683168-25-005521 Jul 30, 2025
ARS FORM ARS 0001683168-25-005522 Jul 30, 2025 Dec 31, 2024
DEF 14A DEFINITIVE PROXY 0001683168-25-005520 Jul 30, 2025 Sep 11, 2025
8-K CURRENT REPORT 0001683168-25-005392 Jul 25, 2025
8-K CURRENT REPORT 0001683168-25-004948 Jul 7, 2025
8-K CURRENT REPORT 0001683168-25-004759 Jun 26, 2025 Jun 25, 2025
3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011890 Jun 18, 2025 Jun 6, 2025
8-K FORM 8-K 0001683168-25-004421 Jun 12, 2025 Jun 6, 2025
4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011424 Jun 11, 2025 Jun 10, 2025
4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011423 Jun 11, 2025 Jun 10, 2025
4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011326 Jun 10, 2025 Jun 9, 2025
4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010155 May 23, 2025 May 21, 2025
4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-009985 May 21, 2025 May 20, 2025
8-K CURRENT REPORT 0001683168-25-003715 May 15, 2025
10-Q FORM 10-Q 0001683168-25-003719 May 15, 2025 Mar 31, 2025
8-K FORM 8-K 0001683168-25-003237 May 7, 2025
8-K FORM 8-K 0001683168-25-002725 Apr 22, 2025 Apr 17, 2025
8-K CURRENT REPORT 0001683168-25-002355 Apr 9, 2025
8-K CURRENT REPORT 0001683168-25-002131 Mar 31, 2025
10-K FORM 10-K FOR DEC 2024 0001683168-25-002134 Mar 31, 2025 Dec 31, 2024
3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-004347 Mar 4, 2025 Feb 19, 2025
8-K FORM 8-K 0001683168-25-001137 Feb 20, 2025 Feb 19, 2025
SCHEDULE 13G/A 0001649553-25-000039 Feb 7, 2025
424B3 PROSPECTUS 0001683168-25-000577 Jan 29, 2025
D 0001123292-25-000029 Jan 28, 2025
D 0001123292-25-000031 Jan 28, 2025
EFFECT 9999999995-25-000224 Jan 28, 2025
D 0001123292-25-000027 Jan 28, 2025
CORRESP 0001683168-25-000550 Jan 27, 2025
UPLOAD 0000000000-25-000806 Jan 24, 2025
SCHEDULE 13G 0001493152-25-003376 Jan 23, 2025
S-1 S-1 0001683168-25-000460 Jan 21, 2025
424B5 FORM 424B5 0001683168-25-000413 Jan 17, 2025
8-K CURRENT REPORT 0001683168-25-000426 Jan 17, 2025 Jan 16, 2025
SCHEDULE 13G 0001213900-25-004657 Jan 17, 2025
424B5 PROSPECTUS 0001683168-25-000356 Jan 15, 2025
8-K CURRENT REPORT 0001683168-25-000384 Jan 15, 2025 Jan 14, 2025
8-K CURRENT REPORT 0001683168-25-000347 Jan 14, 2025 Jan 13, 2025
424B5 PROSPECTUS 0001683168-25-000324 Jan 14, 2025
8-K CURRENT REPORT 0001683168-25-000274 Jan 13, 2025
D 0001123292-25-000005 Jan 7, 2025
D 0001123292-25-000003 Jan 3, 2025
SCHEDULE 13G 0001213900-24-113155 Dec 27, 2024
8-K FORM 8-K 0001683168-24-008984 Dec 26, 2024 Dec 23, 2024